Collaborative Development Program Clause Samples

The Collaborative Development Program clause establishes the framework for two or more parties to jointly develop a product, technology, or service. It typically outlines the roles and responsibilities of each participant, the process for sharing resources and information, and the management of intellectual property created during the collaboration. By clearly defining how the parties will work together and handle joint outputs, this clause ensures effective cooperation and helps prevent disputes over contributions, ownership, and use of jointly developed assets.
Collaborative Development Program. Subject to the terms and conditions set forth herein, ATMI and IM will conduct the Collaborative Development Program in accordance with an agreed upon written plan describing the development activities to be conducted by each party and the anticipated characteristics and properties of the developed technologies (the “Development Plan”). A draft version of the Development Plan is attached hereto as Annex 2; the ATMI and IM Project Managers shall collaboratively and by mutual agreement develop and document the complete initial Development Plan within [*] of the Effective Date of this CDP. The Development Plan may be updated from time to time, subject to mutual written agreement of the parties and when agreed upon will be incorporated into this CDP, superseding or supplementing the previous Development Plan. For clarity, IM HPC Systems will only be used per the Development Plan pursuant to this CDP, or as may otherwise be agreed by the parties in subsequent revisions of the Development Plan, or by written agreement, e.g. subsequent CDPs in other Fields. Each party will commit the necessary resources in equipment, facilities and personnel to complete its respective tasks in accordance with the Development Plan, including the resources listed in Annex 2. Except as stated in Annex 2 and as set forth below, IM and ATMI will each bear their respective costs associated with the Collaborative Development Program. The parties are committed to Phase I of the Collaborative Development Program without right of termination, except for breach as consistent with Section 10.2 of the Agreement.
View SourceView Similar (3)
Collaborative Development Program. Subject to the terms and conditions set forth herein, Elpida and IM will conduct CDP(s) in accordance with an agreed upon written plan describing the Services to be conducted by each party and the target specification to be met through the Services (“Development Plan”). The Development Plan for the DRAM CDP is attached hereto as Exhibit A-1 and is hereby incorporated into this Agreement. The Service fees to support the FTE resources necessary to implement the Development Plan are set forth in the quote attached as Exhibit B and herein incorporated by reference. A Development Plan may be revised from time to time by mutual written agreement of the parties. Elpida agrees to pay the fees and royalties as set forth in Section 5 in accordance with the terms of this Agreement.
View SourceView Similar (3)
Collaborative Development Program. Subject to the terms and conditions set forth herein, including the payment of CDP Service Fees by GF as set forth in Section 6.1, GF and IM will conduct the CDP in accordance with the Development Plan attached hereto as Exhibit A, which is hereby incorporated into this Agreement. The Development Plan will consist of a series of separate development activities (hereinafter “Project(s)”) based on the initial program applications listed in Exhibit A. Each Project shall be assigned one of three (3) categories (“Project Categories”) as identified in Sections 6.3.1, 6.3.2 and 6.
View SourceView Similar (2)
Collaborative Development Program. Subject to the terms and conditions of this Agreement, the parties shall conduct a collaborative development program to design one or more Gene Therapy Products suitable for clinical development and commercialization by Celladon in the Therapeutic Field, as more fully described below in this Article 2 (collectively, the "COLLABORATION"). The parties shall conduct the Collaboration during the Collaboration Term in accordance with a written development plan to be mutually agreed upon within 60 days after the Effective Date and attached hereto as EXHIBIT A (the "DEVELOPMENT Plan"). A Development Plan shall be created and mutually agreed upon by the parties for each 12 month period of the Collaboration. The Development Plan shall set forth the activities to be performed by TGC, the estimated timeline for conduct of such activities and an estimated budget for the Development Plan activities (the "BUDGET"). The parties shall report on the progress made pursuant to the goals of the Development Plan, revise and update such activities, Budget, and timeline as necessary, on a quarterly basis during the Collaboration Term. If modifications in the activities or timeline of activities conducted under the Development Plan are requested by Celladon, TGC shall make good faith efforts to accommodate such requests within the parameters of conducting its other programs, and taking into account its facility, capacity and resource constraints. If activities contemplated by the Development Plan are cancelled by Celladon less than [*] from their initiation, Celladon shall be responsible for non-cancelable costs incurred by TGC in preparation for such activities and shall be responsible for the hours or manufacturing facility time allocated to such activities [*]. At any time, and from time to time, during the Term or during any period when Celladon's license under Section 4.2(b) is in effect, Celladon may, in its sole discretion, designate any Selected Product by written notice thereof to TGC.
View Source
Collaborative Development Program a) Goal. The Parties will collaborate in a Collaborative Development Program to achieve […***…], as more expressly set forth in the Collaborative Development Plan.
View Source
Collaborative Development Program 
View SourceView Similar (8)

Related to Collaborative Development Program

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Research Program The term “

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in ▇▇▇▇▇, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.